PLYMOUTH MEETING, PA — INOVIO (Nasdaq: INO) announced that it will participate in several upcoming scientific and investor conferences in February and March.
The biotechnology company said it will present at the American Association for Cancer Research Immuno-Oncology Conference in Los Angeles on February 18 during Poster Session A from 7:30 p.m. to 10 p.m. PT.
The poster presentation is titled “Treatment of RRP with DNA immunotherapy INO-3107 induces activation and enrichment of pro-inflammatory CD4+ T cell responses in blood and airways of patients with clinical response.”
INOVIO will also participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25 in a virtual fireside chat scheduled from 12:40 p.m. to 1:10 p.m. ET. A webcast will be available here.
On March 4, the company is scheduled to present at the Festival of Biologics in San Diego at 3:10 p.m. PT. The presentation will address safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies in a Phase 1 trial involving healthy adults.
INOVIO is also slated to participate in the Citizens Life Sciences Conference in Miami Beach on March 10 in a fireside chat from 1:40 p.m. to 2:05 p.m. ET. A webcast will be available here.
The company said abstracts will be posted on its website following presentations and that replays of investor events will be available for 90 days.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.